Sanofi’s dengue vaccine Dengvaxia took another step toward a recommendation from the US Centers for Disease Control and Prevention, but concerns about the implementation of pre-vaccination screening testing still surround the first vaccine for the mosquito-borne illness.
Dengvaxia (dengue tetravalent vaccine, live) poses an unusual public health challenge: the vaccine is indicated only for people with laboratory...







